Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing-Reference-Cited by-同舟云学术

Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing

Published:2023-02 Issue: Volume:513 Page:113420
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Sims Matthew D.,Podolsky Robert H.,Childers Karen L.,Higgins Barbara,Trueman Jillian,Homayouni Ramin,Voss Daniel R.,Berkiw-Scenna Natalie,Keil Hans,Kennedy Richard H.,Maine Gabriel N.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference13 articles.

1. Dried blood spot as an alternative to plasma/serum for SARS-CoV-2 IgG detection, an opportunity to be sized to facilitate COVID-19 surveillance among schoolchildren;Amendola;Pediatr. Infect. Dis. J.,2021

2. Statistical methods for assessing agreement between two methods of clinical measurement;Bland;Lancet (London, England),1986

3. Self-sampling of capillary blood for SARS-CoV-2 serology;Brown;Sci. Rep.,2021

4. Dried blood spots may offer route to wider antibody testing;Kuehn;JAMA,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of dried blood spots in the detection of coronavirus disease 2019 (COVID-19): A systematic review;Indian Journal of Medical Microbiology;2024-09

2. Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022;Influenza and Other Respiratory Viruses;2024-07

3. High pre‐Delta and early‐Omicron SARS‐CoV‐2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo);Journal of Medical Virology;2024-03

4. Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022;The Journal of Infectious Diseases;2024-02-23

5. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19;Frontiers in Public Health;2023-12-28